| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
9,910 |
8,801 |
$695K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
5,625 |
5,004 |
$126K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,607 |
3,325 |
$52K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
120 |
117 |
$5K |
| 82607 |
|
965 |
816 |
$1K |
| 82746 |
|
748 |
641 |
$741.30 |
| 80061 |
Lipid panel |
1,882 |
1,823 |
$288.87 |
| 80053 |
Comprehensive metabolic panel |
2,785 |
2,641 |
$273.64 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
879 |
789 |
$151.34 |
| 82728 |
|
817 |
754 |
$149.82 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,756 |
2,603 |
$143.21 |
| 86141 |
|
156 |
73 |
$90.65 |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,241 |
1,201 |
$77.39 |
| 36415 |
Collection of venous blood by venipuncture |
3,297 |
3,089 |
$55.12 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,684 |
1,554 |
$52.80 |
| 84153 |
|
153 |
123 |
$48.99 |
| 83550 |
|
793 |
730 |
$46.20 |
| 83540 |
|
802 |
742 |
$27.00 |
| 85045 |
|
510 |
466 |
$18.99 |
| 81001 |
|
1,257 |
1,233 |
$11.80 |
| 82043 |
|
562 |
549 |
$4.30 |
| 82570 |
|
114 |
112 |
$3.00 |
| 84550 |
|
375 |
369 |
$0.00 |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
133 |
131 |
$0.00 |
| 84439 |
|
13 |
13 |
$0.00 |
| 85610 |
|
14 |
14 |
$0.00 |
| 85651 |
|
189 |
187 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
59 |
56 |
$0.00 |
| 86140 |
|
37 |
37 |
$0.00 |